Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
development. With over 18,000 students and a strong international community, CZU is a dynamic and modern institution committed to excellence in research, innovation, and education. CZU consistently ranks among
-
. Development Financial Support: Annual salary of 90 million KRW, including legal contributions (e.g., 4 major insurances). Research Funding: Opportunity for concurrent participation in other projects and
-
in cancer treatment, i.e. protein/antibody engineering, adoptive T cell therapy, CAR T cells, etc. Humanitas Research center is equipped with newly developed laboratories and a wide range of state
-
Gerardo/Fondazione Tettamanti (Professor Andrea Biondi). The Applicant should be a strongly motivated fellow with a strong background in cellular and molecular immunology and have the potential to develop
-
should have a strong track record of scientific accomplishments with international recognition. We seek an outstanding investigator to join our research center with a focus on developing new devices
-
, interdisciplinary research environment. Upon successful evaluation, the appointment may be extended. Your Role You will develop and lead a cutting-edge research program focused on immune mechanisms in
-
collegial, interdisciplinary environment with world-class research infrastructure. Upon successful evaluation, the appointment may be extended. Your Role You will develop and lead a cutting-edge research
-
the following documents to the attention of EBRI Scientific Director, Prof. Enrico Cherubini, via email at: scientific.assist@ebri.it A one-page cover letter, a curriculum vitae, list of publications, a short
-
research activities to complement the current expertise of the present SISSA faculty members, as well as to attract external funds, take an active part in the SISSA PhD teaching programme, and supervise
-
Group Leaders and Postdoctoral Researchers: Global Call for Scientific Talent at Fondazione Telethon
our mission-driven network. As a leading biomedical research foundation dedicated to discovering and developing therapies for rare genetic diseases, we offer a unique environment that bridges basic